Journal
Neuro-Oncology
Publication Date
5-15-2020
Volume
22
Issue
5
First Page
705
Last Page
717
Document Type
Open Access Publication
DOI
10.1093/neuonc/noz232
Rights and Permissions
Timothy F Cloughesy, Andrew Brenner, John F de Groot, Nicholas A Butowski, Leor Zach, Jian L Campian, Benjamin M Ellingson, Laurence S Freedman, Yael C Cohen, Noa Lowenton-Spier, Tamar Rachmilewitz Minei, Shifra Fain Shmueli, GLOBE Study Investigators, Patrick Y Wen, A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE), Neuro-Oncology, Volume 22, Issue 5, May 2020, Pages 705–717, https://doi.org/10.1093/neuonc/noz232. © The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Cloughesy, Timothy F; Brenner, Andrew; de Groot, John F; Butowski, Nicholas A; Zach, Leor; Campian, Jian L; Ellingson, Benjamin M; Freedman, Laurence S; Cohen, Yael C; Lowenton-Spier, Noa; Rachmilewitz Minei, Tamar; Fain Shmueli, Shifra; GLOBE Study Investigators; and Wen, Patrick Y, "A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)." Neuro-Oncology. 22, 5. 705 - 717. (2020).
https://digitalcommons.wustl.edu/oa_4/1189
Additional Links
Supplemental material is available for this article at publisher site.
